To include your compound in the COVID-19 Resource Center, submit it here.

Plasma biomarker may aid AD diagnosis

In a study published in Nature, Japanese researchers identified a plasma biomarker of brain beta amyloid burden that had an accuracy of about 90% compared against PET imaging, offering the possibility

Read the full 310 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE